ArticleInternational urology and nephrology2025
Mortality trends of renal diseases due to hypertension in adults: an analysis of gender, race, place of death, and geographical disparities in the United States from 1999 to 2020.
Article in International urology and nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mortality trends and demographics due to hypertensive nephrosclerosis in older adults from 1999-2020.Journal of human hypertension · 2026Article
- Response to comment on "Mortality trends of renal diseases due to hypertension in adults: an analysis of gender, race, place of death and geographical disparities in the United States from 1999 to 2020".International urology and nephrology · 2026Article
- Renal failure mortality, 1999-2022: exploring demographic and regional trends and the impact of the COVID-19 pandemic.BMC nephrology · 2026Article
Corrections and comments
- Commented on by
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHypertension-related renal diseases remain a significant healthcare concern, particularly in the United States, owing to the higher mortality rate across different demographic groups. This retrospective study aimed to analyze trends in mortality rates of hypertension-related kidney diseases stratified by age, race, gender, urbanization, state, and place of death.
methodsDatabase of Center of Disease Control and Prevention (CDC) WONDER was used to extract death certificates among adults in US population from 1999 to 2020 using ICD codes. Gender, race, location of death, urbanization, and geographic location per state were used to determine age-adjusted mortality rates (AAMR) per 1,000,000 at a significant level of p < 0.05. Annual percentage changes (APC) and average annual percentage changes (AAPC) were computed using the Joinpoint Regression Program.
resultsFrom 1999 to 2020, about 590,139 were reported among adults with a variable trend having a spike of AAMR from 49.5 in 1999 to 140.2 in 2000 followed by another sudden rise in AAMR from 177.5 in 2010 to a peak of 257.4 (APC: 4.85) in 2012. Then there is notable decline to 46.8 (APC: 46.89) in 2015 and afterward, a steady rise to 77.1 (APC: 16.69) observed in 2020. Overall, males (144.9) had higher AAMRs than females (109.2) throughout the study period with females having more deaths. Among races, African Americans (246.2) had highest AAMR among all followed by Hispanics (124.8), American Alaskans (118.6), Whites (111.4), and lastly Asians (102.9). About half deaths were reported in medical facilities (49.44%) with least reported in hospice (3.29%). The highest AAMRs were observed in non-metropolitan regions (142.2) compared to the large metropolitan (114.1) having lowest AAMR with small metropolitan (129.9) in between. The state of Utah (66.5) was observed lowest AAMR in contrast with the state of North Dakota (191.2) having highest AAMR among all states.
conclusionHypertension-related renal diseases were responsible for 590,139 deaths. Males, African American, non-metropolitan areas, and the state of Dakota demonstrated the highest AAMR. Further research is needed to understand the root cause of these disparities.
Indexed as
Identifiers
40183882What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.